Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Doctors can see more patients without sacrificing the quality of care or increasing stress for the team, improving efficiency, results, and revenue
Can hunger patterns change after switching
Practical protocols and real-world considerations Clinical trial data is generated under controlled conditions with careful patient selection, regular monitoring, and professional oversight
Based on the clinical trial population and the medications mechanism, individuals who may benefit most from retatrutide once it becomes available include: Adults with a BMI of 30 or greater (obesity) Adults with a BMI of 27 or greater who have weight-related conditions such as type 2 diabetes, hypertension, dyslipidemia, or sleep apnea Individuals who have not achieved adequate results with semaglutide or tirzepatide Patients seeking greater weight loss than what current medications provide Individuals with metabolic dysfunction-associated steatohepatitis (MASH) given the glucagon receptors role in liver fat metabolism Retatrutide may not be appropriate for individuals with a history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2, severe gastrointestinal disorders, or a history of pancreatitis
